A recent study in patients with SCA3 revealed notable correlations between increased serum NfL levels and neurometabolite abnormalities, specifically decreased cerebellar NAA/choline and NAA/creatine ratios, reflective of neuronal degeneration in the cerebellum (Chen et al., 2023). The gene discussed is NEFL; the disease is Spinocerebellar ataxia type 3.